|
FAM157A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.215700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.072400E-02 |
| Normal-vs-Stage2 |
8.464100E-02 |
| Normal-vs-Stage3 |
4.861800E-01 |
| Normal-vs-Stage4 |
7.502200E-01 |
| Stage1-vs-Stage2 |
4.095000E-01 |
| Stage1-vs-Stage3 |
4.333600E-01 |
| Stage1-vs-Stage4 |
2.897800E-01 |
| Stage2-vs-Stage3 |
1.981780E-01 |
| Stage2-vs-Stage4 |
1.436410E-01 |
| Stage3-vs-Stage4 |
7.590200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.293990E-01 |
| Normal-vs-AfricanAmerican |
2.090800E-01 |
| Normal-vs-Asian |
3.841600E-02 |
| Caucasian-vs-AfricanAmerican |
6.311600E-01 |
| Caucasian-vs-Asian |
2.589200E-01 |
| AfricanAmerican-vs-Asian |
4.091600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.677000E-01 |
| Normal-vs-Female |
2.872400E-02 |
| Male-vs-Female |
1.447180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.869600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.472300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.762150E-01 |
| Normal-vs-Age(81-100Yrs) |
5.385400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.353750E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.101900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.620000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.121000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.741400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.883400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.176190E-01 |
| Normal-vs-Grade 2 |
1.109930E-02 |
| Normal-vs-Grade 3 |
4.668600E-01 |
| Normal-vs-Grade 4 |
6.683200E-01 |
| Grade 1-vs-Grade 2 |
2.671200E-01 |
| Grade 1-vs-Grade 3 |
1.600430E-01 |
| Grade 1-vs-Grade 4 |
2.530100E-02 |
| Grade 2-vs-Grade 3 |
3.025500E-02 |
| Grade 2-vs-Grade 4 |
1.963530E-02 |
| Grade 3-vs-Grade 4 |
2.703200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.194300E-02 |
| Normal-vs-ccB subtype |
5.573200E-01 |
| ccA subtype-vs-ccB subtype |
6.644400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.928500E-02 |
| Normal-vs-N1 |
3.679800E-01 |
| N0-vs-N1 |
1.438230E-01 |
|
|
